BioNTech SE (BNTX) Cash & Current Investments (2018 - 2025)

BioNTech SE has reported Cash & Current Investments for 8 years, with the latest figure at $18.4 billion in Q4 2025.

• Quarterly Cash & Current Investments fell 5.67% year-over-year to $18.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.4 billion (down 5.67% YoY) and the FY2025 annual result came in at $17.9 billion, down 8.44% from the prior year.
• Cash & Current Investments climbed to $18.4 billion in Q4 2025 per BNTX's latest filing, from $17.0 billion in the prior quarter.
• Over five years, Cash & Current Investments peaked at $19.5 billion in Q4 2024 and troughed at $432.8 million in Q3 2021.
• A 5-year average of $12.1 billion and a median of $15.4 billion in 2025 frame the typical range for Cash & Current Investments.
• The widest YoY moves for Cash & Current Investments: up 3039.57% in 2022, down 15.45% in 2022.
• Over 5 years, Cash & Current Investments stood at $2.4 billion in 2021, then soared by 504.7% to $14.3 billion in 2022, then increased by 24.09% to $17.8 billion in 2023, then advanced by 9.51% to $19.5 billion in 2024, then slipped by 5.67% to $18.4 billion in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $18.4 billion, $17.0 billion, and $15.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.